Services
EnquBio's Comprehensive Drug Discovery Solutions & Services
At EnquBio, our expert team delivers high quality, efficient, and dependable R&D solutions that enable pharmaceutical and biotech partners to advance and expand their drug development pipelines.
- Discovery Biology
- Plate-Based Pharmacology
- Ex Vivo Pharmacology
-
In Vivo Pharmacology
- Inflammation & Autoimmune Diseases Models
- Syngeneic and Cell Line-Derived Xenograft (CDX) Models
- Humanized Immuno-Oncology Models
- FLI and BLI based optical in vivo imaging for orthotopic models and drug biodistribution
- Pharmacokinetic and Pharmacodynamic (PK/PD)
- Non-GLP Toxicology
- Other In Vivo Efficacy Models
- Biomarker & Bioanalysis
- Therapeutic Areas
Discovery Biology
Drive faster drug target validation and development with EnquBio’s Discovery Biology Services. Our specialized team combine genome editing, custom cell line engineering, iPSC model systems, and functional assays to link molecular targets to phenotypic outcomes across a broad range of therapeutic areas. By harnessing cutting-edge platforms and efficient, cost-conscious workflows, we simplify early-stage research, allowing you to prioritize and propel your most promising candidates forward.
Explore More
Plate-Based Pharmacology
Streamline your drug discovery efforts with EnquBio’s expert-led Plate-Based Pharmacology services. Our validated and custom assay platforms support high-throughput screening (384- and 1536-well plates), hit-to-lead progression, and lead optimization across diverse therapeutic areas, target classes, and modalities. Backed by cutting-edge instrumentation, efficient workflows, and deep domain expertise, we deliver comprehensive pharmacological profiling to accelerate your therapeutic pipeline.
Explore More
Ex Vivo Pharmacology
Ex vivo pharmacology uses freshly collected human and animal tissues, blood, and primary cells to study drug activity outside the body. By preserving multicellular interactions, local signaling, and tissue architecture, these systems provide a more physiologically relevant context than conventional in vitro assays — whether treating fresh samples directly or analyzing samples collected from in vivo studies.
At EnquBio, ex vivo studies can be designed as standalone assays or integrated with our own in vivo studies, so dosing, sample collection, and downstream analysis run under one roof. Our scientists bring more than 10 years of experience supporting global biopharmaceutical companies, generating multidimensional datasets that strengthen mechanism understanding and translational confidence.
In Vivo Pharmacology
At EnquBio, we specialize in guiding model selection and developing customized in vivo systems aligned with your specific research objectives. With extensive experience in preclinical pharmacology, our team delivers industry-leading quality and reproducible data across a wide range of therapeutic areas, positioning us as a trusted and agile partner for your in vivo research programs.
Explore More
Biomarker & Bioanalysis
EnquBio provides integrated biomarker and bioanalytical services for preclinical, translational, and exploratory clinical research. We analyze serum, plasma, PBMCs, whole blood, cell lysates, and tissue-derived samples to evaluate target engagement, pharmacodynamic responses, and treatment-related biological changes.
From established assays to customized, fit-for-purpose methods, our scientists support assay execution, data analysis, and study reporting — delivering reliable, decision-ready data with the flexibility and efficiency needed for exploratory research.
Therapeutic Areas
EnquBio supports drug discovery and development programs across key therapeutic areas, drawing on integrated in vitro, ex vivo, and in vivo pharmacology together with biomarker and bioanalysis platforms. Explore how our capabilities come together within each disease area—from target validation and mechanistic studies to efficacy models, PK/PD, and translational biomarkers.
Explore More